Curative Ventures V LLC has filed its latest holdings report, revealing a substantial investment in Instil Bio, Inc. as of September 30, 2026. This move is significant as it underscores Curative Ventures' ongoing strategy within the biotechnology sector, which is characterized by rapid innovation and competition.

Background

Curative Ventures V LLC is a private investment firm based in Dallas, Texas. The company focuses on investing in various sectors, including biotechnology. The firm has been active in filing Form 13F-HR, which reports its holdings in publicly traded companies. Recent filings include reports from July 31, 2026, and April 29, 2026, among others.

What the Filing Says

According to the filing, Curative Ventures V LLC reported a total investment value of $13,748,789 in Instil Bio, Inc., holding 1,899,004 shares of the company's common stock. The filing indicates that the firm has shared voting authority over these shares.

Impact

This filing may affect Curative Ventures' stakeholders and the broader biotechnology industry. As Curative Ventures continues to invest in biotech firms like Instil Bio, it signals confidence in the sector's growth potential. Competitors in the biotechnology space will likely be watching these developments closely to gauge market trends and investment strategies.

What's Next

The filing does not say what happens next.